Skip to content
Governance Register

← US public companies

Avalon Pharmaceuticals INC

SEC CIK 1162192 · AVRX · last insider filing 2009-06-01

Directors (from insider filings)

NameCapacity as filedFilings
Lorimier Bradley G Director filed 2006 - 2009
Carter Kenneth C Director · President and CEO filed 2006 - 2009
Kabakoff David S Director filed 2006 - 2008
Washecka William H Director filed 2006 - 2008
Frost Philip Director filed 2008 - 2008
Kurman Michael R Director filed 2006 - 2008
Royston Ivor Director filed 2006 - 2008
Walton Alan G Director filed 2006 - 2008
Scott William A Director filed 2006 - 2008
Whitaker Raymond J Director filed 2006 - 2007

Officers (from insider filings)

NameTitle as filedFilings
Hamilton J Michael Chief Medical Officer filed 2006 - 2009
Winzer C Eric EVP & Chief Financial Officer filed 2007 - 2008
Horrigan Stephen K VP of Research filed 2007 - 2008
Farmer Glen A Principal Accounting Officer filed 2006 - 2008
Bol David K VP Pharmaceutical Development filed 2006 - 2006
David Thomas G General Counsel & Sr VP Oper. filed 2006 - 2006
Lessing Gary Chief Financial Officer filed 2006 - 2006
Muth David EVP & Chief Business Officer filed 2006 - 2006

About this record

From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.

Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.